Progesterone receptor and Androgen receptor

The 'Progesterone receptor and Androgen receptor' is an incorrect grouping for a single therapeutic target. Both Progesterone receptor (PR) and Androgen receptor (AR) are distinct members of the steroid hormone nuclear receptor family, sharing structural homology and a common mechanism of action as transcription factors. However, they are activated by different ligands (progesterone for PR; androgens for AR) and mediate distinct biological functions, primarily governing female and male reproductive biology, respectively. They are individually critical therapeutic targets in various hormone-dependent cancers (e.g., PR in breast and endometrial cancer, AR in prostate cancer) and endocrine disorders. While related in their classification, their specific roles and therapeutic interventions warrant separate consideration.

Other names

PR and ARNuclear receptor subfamily 3 group C member 3 and Nuclear receptor subfamily 3 group C member 4NR3C3 and NR3C4

Both are nuclear receptors that bind specific steroid hormones (progesterone for PR, androgens for AR) to regulate gene expression. Agonists stimulate their transcriptional activity, while antagonists block hormone binding or receptor function, thus suppressing downstream gene transcription specific to each receptor.